Balance Sheet

Cash Flow Statement

Amortization Amortization Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Summit Therapeutics (SMMT) Long-Term Debt Issuances (2016 - 2022)

Summit Therapeutics filings provide 3 years of Long-Term Debt Issuances readings, the most recent being $520.0 million for Q4 2022.

Quarterly Long-Term Debt Issuances changed N/A to $520.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $520.0 million through Sep 2023, up 1980.0% year-over-year, with the annual reading at $545.0 million for FY2022, 395.45% up from the prior year.
Long-Term Debt Issuances hit $520.0 million in Q4 2022 for Summit Therapeutics, up from $25.0 million in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at $520.0 million in Q4 2022 and bottomed at $25.0 million in Q1 2022.